• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼠李糖乳杆菌 JB3 通过多种分子作用抑制幽门螺杆菌感染。

Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions.

机构信息

Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.

出版信息

Helicobacter. 2021 Jun;26(3):e12806. doi: 10.1111/hel.12806. Epub 2021 Apr 11.

DOI:10.1111/hel.12806
PMID:33843101
Abstract

BACKGROUND

Eradication of Helicobacter pylori infection is the most direct and effective way for preventing gastric cancer. Lactic acid bacteria are considered as alternative therapeutic agents against H. pylori infection.

METHODS

Effects of Lactobacillus rhamnosus JB3 (LR-JB3) on the virulence gene expression of H. pylori and infection-induced cellular responses of AGS cells were investigated by co-cultivating infected AGS cells with different multiplicity of infections (MOIs) of LR-JB3.

RESULTS

LR-JB3, specifically at a MOI of 25, suppressed the association ability of H. pylori and its induced IL-8 levels, as well as the mRNA levels of vacA, sabA, and fucT of H. pylori, infection-induced Lewis (Le) antigen and Toll-like receptor 4 (TLR4) expressions in AGS cells. However, the apoptosis mediated by infection was inhibited by LR-JB3 in a dose-dependent manner. In addition, autoinducer (AI)-2 was observed to have increased the association ability and fucT expression of H. pylori, and Le antigen and TLR4 expression of AGS cells. Interestingly, an unknown bioactive cue was hypothesized to have been secreted from LR-JB3 at a MOI of 25 to act as an antagonist of AI-2.

CONCLUSIONS

LR-JB3 possesses various means to interfere with H. pylori pathogenesis and infection-induced cellular responses of AGS cells to fight against infection.

摘要

背景

根除幽门螺杆菌感染是预防胃癌的最直接、最有效的方法。乳酸菌被认为是治疗幽门螺杆菌感染的替代治疗药物。

方法

通过共培养感染 AGS 细胞与不同感染复数(MOI)的鼠李糖乳杆菌 JB3(LR-JB3),研究 LR-JB3 对幽门螺杆菌毒力基因表达和感染诱导的 AGS 细胞细胞反应的影响。

结果

LR-JB3,特别是在 MOI 为 25 时,抑制了幽门螺杆菌的结合能力及其诱导的 IL-8 水平,以及幽门螺杆菌的 vacA、sabA 和 fucT 基因、感染诱导的 Lewis(Le)抗原和 Toll 样受体 4(TLR4)表达。然而,LR-JB3 以剂量依赖的方式抑制了由感染介导的细胞凋亡。此外,发现自诱导物(AI)-2 增加了幽门螺杆菌的结合能力和 fucT 表达,以及 AGS 细胞的 Le 抗原和 TLR4 表达。有趣的是,假设 LR-JB3 在 MOI 为 25 时分泌了一种未知的生物活性信号分子,作为 AI-2 的拮抗剂。

结论

LR-JB3 具有多种干扰幽门螺杆菌发病机制和感染诱导的 AGS 细胞细胞反应的方法,以抵抗感染。

相似文献

1
Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions.鼠李糖乳杆菌 JB3 通过多种分子作用抑制幽门螺杆菌感染。
Helicobacter. 2021 Jun;26(3):e12806. doi: 10.1111/hel.12806. Epub 2021 Apr 11.
2
Antagonistic Activities of JB3 Against Infection Through Lipid Raft Formation.JB3 通过脂筏形成拮抗感染的活性。
Front Immunol. 2022 Jan 14;12:796177. doi: 10.3389/fimmu.2021.796177. eCollection 2021.
3
Baicalin, Baicalein, and Lactobacillus Rhamnosus JB3 Alleviated Helicobacter pylori Infections in Vitro and in Vivo.黄芩苷、黄芩素和鼠李糖乳杆菌 JB3 体外和体内减轻幽门螺杆菌感染。
J Food Sci. 2018 Dec;83(12):3118-3125. doi: 10.1111/1750-3841.14372. Epub 2018 Nov 23.
4
Effects of Multi-Strain Probiotics on Immune Responses and Metabolic Balance in -Infected Mice.多菌株益生菌对感染小鼠免疫应答和代谢平衡的影响。
Nutrients. 2020 Aug 17;12(8):2476. doi: 10.3390/nu12082476.
5
Effect of Lactobacillus gasseri BIO6369 and Lacticaseibacillus rhamnosus BIO5326 on Gastric Carcinogenesis Induced by Helicobacter pylori Infection.加氏乳杆菌BIO6369和鼠李糖乳杆菌BIO5326对幽门螺杆菌感染诱导的胃癌发生的影响。
Helicobacter. 2024 Jul-Aug;29(4):e13108. doi: 10.1111/hel.13108.
6
Characterization of the immunomodulatory and anti- properties of the human gastric isolate UCO-25A.鉴定人胃分离株 UCO-25A 的免疫调节和抗特性。
Biofouling. 2019 Sep;35(8):922-937. doi: 10.1080/08927014.2019.1675153. Epub 2019 Oct 24.
7
Anti-inflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection.幽门螺杆菌感染背景下胃源植物乳杆菌XB7的抗炎特性
Helicobacter. 2014 Apr;19(2):144-55. doi: 10.1111/hel.12105. Epub 2014 Jan 5.
8
Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism.益生菌通过激活细胞因子信号抑制蛋白(SOCS)表达和信号转导在幽门螺杆菌感染中的抗炎作用:一种新机制。
J Gastroenterol Hepatol. 2010 Jan;25(1):194-202. doi: 10.1111/j.1440-1746.2009.06127.x.
9
Antagonistics of Lactobacillus plantarum ZDY2013 against Helicobacter pylori SS1 and its infection in vitro in human gastric epithelial AGS cells.植物乳杆菌ZDY2013对幽门螺杆菌SS1的体外拮抗作用及其对人胃上皮AGS细胞感染的影响
J Biosci Bioeng. 2018 Oct;126(4):458-463. doi: 10.1016/j.jbiosc.2018.04.003. Epub 2018 Apr 23.
10
Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4.Let-7b 通过靶向 Toll 样受体 4 参与与幽门螺杆菌感染相关的炎症和免疫反应。
PLoS One. 2013;8(2):e56709. doi: 10.1371/journal.pone.0056709. Epub 2013 Feb 20.

引用本文的文献

1
Beyond antibiotics: probiotics as a promising ally against .超越抗生素:益生菌成为对抗……的有前景盟友
Front Pharmacol. 2025 Jul 11;16:1620870. doi: 10.3389/fphar.2025.1620870. eCollection 2025.
2
The current status and prospects of gut microbiota combined with PD-1/PD-L1 inhibitors in the treatment of colorectal cancer: a review.肠道微生物群联合PD-1/PD-L1抑制剂治疗结直肠癌的现状与展望:综述
BMC Gastroenterol. 2025 May 16;25(1):380. doi: 10.1186/s12876-025-03968-y.
3
Effects of Lactobacillus spp. on Helicobacter pylori: A Promising Frontier in the Era of Antibiotic Resistance.
乳酸杆菌属对幽门螺杆菌的影响:抗生素耐药时代的一个有前景的前沿领域。
Probiotics Antimicrob Proteins. 2024 Nov 5. doi: 10.1007/s12602-024-10396-z.
4
Programmed cell death in infection and related gastric cancer.程序性细胞死亡在 感染与相关胃癌中的作用。
Front Cell Infect Microbiol. 2024 Jul 31;14:1416819. doi: 10.3389/fcimb.2024.1416819. eCollection 2024.
5
Screening Probiotics for Anti- and Investigating the Effect of Probiotics on Patients with Infection.筛选具有抗感染作用的益生菌并研究其对感染患者的影响。
Foods. 2024 Jun 13;13(12):1851. doi: 10.3390/foods13121851.
6
Lyophilized cell-free supernatants of Limosilactobacillus fermentum T0701 exhibited antibacterial activity against Helicobacter pylori.发酵乳杆菌T0701的冻干无细胞上清液对幽门螺杆菌具有抗菌活性。
Sci Rep. 2024 Jun 13;14(1):13632. doi: 10.1038/s41598-024-64443-4.
7
infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review.人类感染与植物疗法、益生菌及新兴治疗干预措施:综述
Front Microbiol. 2024 Jan 10;14:1330029. doi: 10.3389/fmicb.2023.1330029. eCollection 2023.
8
Gastric microbiota dysbiosis and infection.胃微生物群失调与感染。
Front Microbiol. 2023 Mar 30;14:1153269. doi: 10.3389/fmicb.2023.1153269. eCollection 2023.
9
GG supplementation on eradication rate and dyspepsia in infection treated with three-in-one bismuth quadruple therapy.补充GG对三联铋剂四联疗法治疗幽门螺杆菌感染的根除率和消化不良的影响
Front Microbiol. 2022 Dec 5;13:932331. doi: 10.3389/fmicb.2022.932331. eCollection 2022.
10
Anti-Helicobacter pylori activity of potential probiotic Lactiplantibacillus pentosus SLC13.潜在益生菌植物乳杆菌 SLC13 抗幽门螺杆菌活性的研究
BMC Microbiol. 2022 Nov 21;22(1):277. doi: 10.1186/s12866-022-02701-z.